KeyBanc analyst Paul Knight maintained a Hold rating on Alpha Teknova (TKNO – Research Report) yesterday. The company’s shares closed yesterday at $2.01.
According to TipRanks, Knight is a 3-star analyst with an average return of 2.1% and a 42.45% success rate. Knight covers the Healthcare sector, focusing on stocks such as West Pharmaceutical Services, Danaher, and Revvity.
Currently, the analyst consensus on Alpha Teknova is a Strong Buy with an average price target of $5.33.
See today’s best-performing stocks on TipRanks >>
Based on Alpha Teknova’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $11.53 million and a GAAP net loss of $7.15 million. In comparison, last year the company earned a revenue of $11.69 million and had a GAAP net loss of $6.2 million
Based on the recent corporate insider activity of 21 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of TKNO in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Alpha Teknova (TKNO) Company Description:
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification.
Read More on TKNO:
- Teknova Reports Third Quarter 2023 Financial Results
- Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023
- Alpha Teknova files to sell 11.3M shares of common stock for holders
- Alpha Teknova launches latest proprietary AAV-Tek product
- Insiders Pour Millions Into These 2 Beaten-Down Stocks, Analysts Say They Could Be Ready to Bounce Back — Here’s Why You Should Take Notice
